Innovative Diagnostic Technology NOWDiagnostics offers a portfolio of OTC and POC diagnostic tests with patented, rapid, one-step immunoassays suitable for in-home and clinical settings, presenting strong potential for partnerships with healthcare providers and retail pharmacies seeking accessible testing solutions.

Expanding Product Line The recent nationwide launch of the First To Know Syphilis Test and collaborations with major players like Labcorp indicate active product expansion and distribution channels, creating opportunities to introduce complementary diagnostic tests or enhance existing offerings through strategic partnerships.

Market Entry & Access With its focus on in-home and onsite testing, NOWDx is positioned to capitalize on growing consumer demand for quick and reliable health diagnostics, especially in the context of infectious diseases like COVID-19 and sexually transmitted infections, opening avenues for sales to retail outlets, telehealth providers, and healthcare networks.

Funding and Growth Potential Having secured $22.5 million in Series B funding and attending major industry conferences, NOWDx demonstrates strong growth potential and investor confidence, making it an attractive partner for companies interested in co-developing new diagnostic solutions or expanding distribution in the rapidly evolving diagnostics market.

Strategic Collaborations Partnerships with organizations like Labcorp and collaborations with government agencies such as BARDA highlight NOWDx's capability to work within clinical and emergency health settings, providing sales opportunities for advanced diagnostic tools across commercial and government-funded healthcare programs.